151. Synthesis and characterisations of copper(II) complexes of 5-methoxyisatin thiosemicarbazones: Effect of N-terminal substitution on DNA/protein binding and biological activities.
- Author
-
Aneesrahman, K.N., Ramaiah, K., Rohini, G., Stefy, G.P., Bhuvanesh, N.S.P., and Sreekanth, A.
- Subjects
- *
THIOSEMICARBAZONES , *PROTEIN binding , *DNA , *COPPER , *VITAMIN C , *PROTEIN-protein interactions , *INTERLEUKIN-23 , *DOXORUBICIN - Abstract
• New copper(II) thiosemicarbazone complexes have been synthesized and characterized. • The DNA/protein interactions of complexes were studied by a variety UV–Vis and fluorescent spectroscopic techniques. • The antimicrobial activity against four different bacteria and five fungi have also been examined. • The antiproliferative activity was evaluated against MCF-7, A459, HeLa and HEK 293 cell lines. • Assay on HEK 293 cell lines showed that the compounds were less toxic to normal cells. The newly synthesized ligands (HL1 - HL3) of 5-methoxyisatin thiosemicarbazone with different N-terminal substituents and their copper(II) complexes 1 – 3 respectively were exposed to spectral and structural characterization. The spectral studies reveal that the ligands show a tridentate mode of binding (ONS donor) with Cu(II) to form square planar complexes. The crystal structure of the ligand HL1 and complex 1 were confirmed by single crystal XRD. The compounds were subjected to DNA/BSA interaction studies using electronic and fluorescence spectroscopic techniques. The binding studies showed that, the complexes (1 – 3) were able to bind with DNA/BSA macromolecules with good binding constant. In which 1 (K b = 0.83 × 105 M−1) shows good interaction with the DNA while 3 shows better interaction with BSA (K b = 2.4 × 105 M−1). The complexes (1 – 3) were also tested for antimicrobial activity, radical scavenging activity and in vitro anti-proliferative activity. Complex 3 have shown potent efficacy with broad spectrum antimicrobial activity against the microorganisms, whereas the complex 1 has shown decent scavenging properties compared to the reference drug (ascorbic acid) with an IC 50 value of 19.23 ± 1.05 µM. Further the, anti-proliferative activity study revealed that, the complex 1 has exhibited broad spectrum activity against MCF-7, A549 and HeLa with IC 50 values 14.83 ± 0.45 μM, 17.88 ± 0.16 μM and 6.89 ± 0.42 μM, respectively compared to standard drug Doxorubicin. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF